Global ADHD Drugs Market- Size|Share| Trends| Forecast

  • Published on

  • View

  • Download

Embed Size (px)


  • Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018

    Published Date: Oct 2014

    Global ADHD Drugs Market 2014-2018

  • Report Description

    About ADHDADHD is a psychiatric disorder, which is mostly found in children. However, adults have alsobeen reported to be diagnosed with ADHD. The patients with ADHD suffer from severalproblems including hyperactivity, impulsiveness, and lack of focus and concentration. Thecauses of ADHD are not known. It is believed to be linked with genetic and environmentalcauses. However, it has been reported to be related with the decrease in the extraneuronallevels of norepinephrine and dopamine. In addition, the patients have an abnormality inthe brain structure. It is more prevalent in boys than girls. The management of ADHD isdone by counseling, medications, and lifestyle changes.Global ADHD Drugs market to grow at a CAGR of 5.33 percent over the period 2013-2018.

    Get Complete Report At:

    Covered in this ReportThis report covers the present scenario and the growth prospects of the Global ADHDDrugs market for the period 2014-2018. To calculate the market size, the report considersthe revenue generated from the sales of various therapies used in the treatment of ADHD,which include:

  • Report Description

    Stimulants Non-stimulantsThe Global ADHD Drugs Market 2014-2018, has been prepared based on an in-depthmarket analysis with inputs from industry experts. The report covers the Americas, and theEMEA and APAC regions; it also covers the Global ADHD Drugs market landscape and itsgrowth prospects in the coming years. The report also includes a discussion of the keyvendors operating in this market.

    Key Regions Americas APAC EMEA

    Enquire About this report:

    Key Vendors Eli Lilly and Janssen Novartis Shire

  • Report Description

    Other Prominent Vendors

    Actavis Alcobra Amarantus Boehringer Ingelheim Concordia Curemark GlaxoSmithKline Hisamitsu Impax Intellipharmaceutics Mylan Neurovance Noven Par Pharmaceuticals Sanofi Shionogi Sunovion Teva Tris Pharma

  • Report Description

    Market Driver Presence of Unmet Need For a full, detailed list, view our report

    Market Challenge Unknown Etiology For a full, detailed list, view our report

    Market Trend Increase in Awareness For a full, detailed list, view our report

    Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

  • Table of Contents

    01 Executive Summary02 List of Abbreviations03 Scope of the Report04 Market Research Methodology05. Market Research Methodology06. Introduction07. Market Landscape08. Market Segmentation by Product Type09. Market Segmentation by Route of Administration10. Market Segmentation by Dosage Form11. Geographical Segmentation12. Key Leading Countries13. Rate of Incidence and Prevalence14. Buying Criteria15. Market Growth Drivers16. Drivers and their Impact17. Market Challenges18. Impact of Drivers and Challenges19. Market Trends20. Trends and their Impact


    Visit us at :

    Stay With Us:

    TELEPHONE: +1 (855) 711-1555


    5933 NE Win Sivers Drive,

    #205, Portland, OR 97220

    United States